FDA Inspection 1056228 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on Jun 4, 2018 in Colorado Springs, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 4, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Colorado Springs, CO (United States)